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Wewere interested to read the article A prospective randomized
comparison of neoprene vs thermoplast hand-based thumb spica
splinting for trapeziometacarpal arthrosis1 in volume 21 2013 issue
of the Osteoarthritis and Cartilage. We always appreciate the time,
effort, and dedication it takes to prepare such an article. As hand
therapists, we eagerly read the article looking for any new research
that may provide evidence of the efﬁcacy of orthotic intervention
for patients with thumb carpometacarpal (CMC) osteoarthritis
(OA). This topic has hadmore research thanmany areas of our prac-
tice. This year Bani et al.2 found that a custom made CMC orthotic
device produced decreased pain, increased grip and pinch strength,
and increased hand function. They measured outcomes at baseline,
30, 60, and 90 days. Their outcomes included a visual analogue
scale to assess pain, along with a disability of the arm, shoulder,
and hand questionnaire (DASH) to assess function, and a dyna-
mometer and pinch gaugewere used to assess strength. In compar-
ison, the Becker et al.1 study published in your journal had some
methodological shortcomings that we feel need to be addressed.
Initially the authors performed a-priori sample size analysis us-
ing a two-tailed Student’s t test that estimated the need to evaluate
60 participants to detect a clinically relevant difference of 10 points
in follow-up DASH scores between the two prospective cohorts at
90% power, and a signiﬁcance level of 0.05. However when the au-
thors were close to their target enrolment number of 60 subjects,
approximately half of the study population had not returned for
the 5e15 weeks evaluation and the target was raised to 120 pa-
tients. More than 43% of the subjects dropped out of the study.
We do not know if they wore the orthoses, were happy with their
orthotic device, or threw it away the day after they received it. This
study had a very large drop out rate that was addressed by adding
more subjects to the study as the study progressed. It was also re-
ported that “additional radiological assessment was not considered
necessary for the diagnoses” so the reader does not know whata.2014.02.001.
ternational. Published by Elsevier Lstage of OA of the subjects had and how the stage of OA could
have inﬂuenced the results of the study.
The wearing schedule of the devices was not provided, so it
would be difﬁcult to reproduce this study. The follow up period
of this trial was between 5 and 15 weeks that seems to be very
limited and provides the reader with knowledge of only the
short-term beneﬁts of one orthotic device compared the other. In
the Becker et al.1 study one person also received a night orthoses
for carpal tunnel syndrome. This indicates one subject received
more than one orthotic device, so it would be difﬁcult to determine
for which device he was answering the questionnaire.
In the Bani et al.2 study, participants that received the custom
made orthotic device achieved a clinically and statistically signiﬁ-
cant difference of 13 points in their DASH score. None of the sub-
jects in the Becker et al.1 study achieved a meaningful change in
their reported DASH score indicating improved hand function.
The authors note that many of the gathered DASH scores were
not validly completed. They state, “Any DASH with four and ﬁve
missing items.were analyzed1.” A DASH is valid with up to three
missing questions, otherwise the DASH is not to be scored3. It is
difﬁcult to understand the authors’ conclusion that either orthosis
reduced disability.
Finally, the study was not a crossover design so the subjects did
not have the opportunity to compare one device to the other. It
seems reasonable that most individuals would prefer a soft device
to a hard device. We would certainly prefer to sit on a cushioned
chair rather than a hard wooden chair. Sillem et al.4 also cited by
Becker, found in their comparison of a custom and a prefabricated
neoprene orthosis that patients preferred the neoprene 63% to
custom 37%, as did Weiss et al.5 and Becker. Although comfort is
important, the importance is in the choice of which orthosis ﬁts
the orthopaedic need of the patient seeking intervention6. Should
this need always be met due to only price or comfort? It is also
questionable that price was a part of their advice to patients,
when price was not a part of this study. Neoprene orthoses are
rarely covered by insurance in an outpatient setting, creating
more out of pocket cost for the person. Also noted, the Bani et al.2
study indicated that care was taken to ensure that the thumb was
positioned to prevent dislocation of the upper end of thetd. All rights reserved.
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thumbwas important. So to conclude that there is minimum differ-
ence between the two splints seems to overstate the ﬁndings of the
Becker et al.1 study. It should also be noted that there is moderate to
high evidence that joint protection education and exercise inter-
vention reduces pain and increases function in the treatment of in-
dividuals with CMC OAwhich can be readily addressed in the same
therapy visit as a custom orthotic application7.
Sincerely,
Kristin Valdes OTD, OT, CHT
Virginia H. O’Brien, OTD, OTR/L, CHT
Lisa M. Cyr, OTD, OTR/L, CHT
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